Angela Dawson

•  University of Kentucky, College of Medicine – Lexington, KY
• Kentucky Wesleyan College – Owensboro, KY

 Fellow: American Board of Obstetrician and Gynecologist

• Kentucky License Number: 41041
• Indiana License Number: 01065120A

•  Central Association of Obstetricians and Gynecologists
• American College of Obstetrics and Gynecology
• Kentucky Medical Association
• Daviess County Medical Associatio

• An open-label, parallel-group.randomized, multicenter study to assess the safety and efficacy of vilaprisan in subjects with uterine fibroids versus standard of care. BAYER
• Phase 3, randomized, double-blind, multicenter, placebo-controlled study evaluating the efficacy, safety and tolerability of elagolix alone and in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women 18 to 51 years of age. MI2-815
• Extension study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain. MI2-667
• A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Elagolix in subjects with moderate to serve endometriosis – associated pain. M12-66